Literature DB >> 11268289

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.

H Okada1, I F Pollack, F Lieberman, L D Lunsford, D Kondziolka, D Schiff, J Attanucci, H Edington, W Chambers, P Kalinski, D Kinzler, T Whiteside, E Elder, D Potter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11268289     DOI： 10.1089/104303401300042528

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  19 in total

1.  EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.

Authors:  Manabu Hatano; Junichi Eguchi; Tomohide Tatsumi; Naruo Kuwashima; Jill E Dusak; Michel S Kinch; Ian F Pollack; Ronald L Hamilton; Walter J Storkus; Hideho Okada
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

Review 2.  Ependymomas: development of immunotherapeutic strategies.

Authors:  Ian F Pollack; Regina I Jakacki; Lisa H Butterfield; Hideho Okada
Journal:  Expert Rev Neurother       Date:  2013-10       Impact factor: 4.618

Review 3.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 4.  Gene therapy and targeted toxins for glioma.

Authors:  Maria G Castro; Marianela Candolfi; Kurt Kroeger; Gwendalyn D King; James F Curtin; Kader Yagiz; Yohei Mineharu; Hikmat Assi; Mia Wibowo; A K M Ghulam Muhammad; David Foulad; Mariana Puntel; Pedro R Lowenstein
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

Review 5.  Evolution of a gene therapy clinical trial. From bench to bedside and back.

Authors:  Laura K Aguilar; Estuardo Aguilar-Cordova
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

6.  Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

Authors:  Ian F Pollack; Regina I Jakacki; Lisa H Butterfield; Ronald L Hamilton; Ashok Panigrahy; Daniel P Normolle; Angela K Connelly; Sharon Dibridge; Gary Mason; Theresa L Whiteside; Hideho Okada
Journal:  J Neurooncol       Date:  2016-09-13       Impact factor: 4.130

7.  Targeted therapy in the treatment of malignant gliomas.

Authors:  Rimas V Lukas; Adrienne Boire; M Kelly Nicholas
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

8.  Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

Authors:  Mayu O Frank; Julia Kaufman; Suyan Tian; Mayte Suárez-Fariñas; Salina Parveen; Nathalie E Blachère; Michael J Morris; Susan Slovin; Howard I Scher; Matthew L Albert; Robert B Darnell
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

9.  Magnetic resonance imaging detects differences in migration between primary and immortalized neural stem cells.

Authors:  Sergey Magnitsky; Raquel M Walton; John H Wolfe; Harish Poptani
Journal:  Acad Radiol       Date:  2008-10       Impact factor: 3.173

Review 10.  Immunotherapy of malignant brain tumors.

Authors:  Duane A Mitchell; Peter E Fecci; John H Sampson
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.